To give you an indication, there is no clinical geneticist post in the Hospital Authority – a very important position in terms of dealing with the…
In Conversation
With over 30 years of experience in the life sciences industry, Angela McFarlane explains why the UK will not be removed from its position in the…
The UK is in itself a global life sciences hub and looked up to by the rest of the world. We have here the opportunity for…
“Last year, we grew over 90 percent in Turkey. Our Turkish affiliate was the Number Three worldwide after the US and China, based on the business…
“Now that China is talking about ‘Made in China’, we need to remember that manufacturing is not just copying or processing, it is about creating and…
“Our common objective is to ensure that everyone in Turkey has access to the best treatments that are available globally."
I see technology as the enabler that creates new possibilities. Imaging devices are becoming more and more sophisticated and portable
As an industry, we understand the necessity to ensure the financial sustainability of the Turkish model of healthcare, but I hope that we can meet on…
“Finally, coming to Hong Kong, the city has a great value proposition in terms of its legal system as well as quality financial and banking services,…
“Overall, the commitment of Pfizer to Turkey is already remarkable: 75 percent of our products consumed in the country are already locally manufactured, while Pfizer’s flagship…
We also collaborate on workshops with industry. There is a fundamental need to educate professionals about treatments and generate awareness of the patient view, and through…
“Turkey's population stands firm at 80 million and is the 17th largest country in the world. Life expectancy is 78 years, 75.3 for men and 80.7…
